Wexford Capital’s Prothena Corp PRTA Stock Holding History

Wexford Capital’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-48,195	Closed	-$1.85M	–	157
2014 Q1	$1.85M	Buy	+48,195	New	+$1.55M	0.14%	91

Other funds holding PRTA

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wexford Capital's PRTA Position: Q2 2014 in Review

Wexford Capital sold out of Prothena Corp (PRTA) in Q2 2014, closing a stake of 48,195 shares — an estimated $1.85M sold.

Wexford Capital first reported a position in PRTA in Q1 2014 and held it in 1 quarter. The position peaked at $1.85M in Q1 2014. 132 funds tracked by Wall St. Rank hold PRTA as of Q2 2014.

Wexford Capital reported no remaining Prothena Corp position as of Q2 2014 after selling out during the quarter.
Wexford Capital sold 48,195 Prothena Corp shares in Q2 2014, an estimated $1.85M.
Wexford Capital first reported a position in Prothena Corp in Q1 2014 and held it in 1 quarter.
Wexford Capital's Prothena Corp position peaked at $1.85M in Q1 2014.
132 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2014.

Based on Wexford Capital's 13F filing for Q2 2014, filed 13 Aug 2014.